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The disease Lupus erythematosus (LE), exhibits a variety of clinical
manifestations with potentially wide-ranging multi-organ damage
to joints, tendons, kidney, lung, heart, blood vessels, central
nervous system and skin [1,2] Systemic changes are likely to
trigger organ speciﬁc manifestation of the disease. Here, we
provide the data examined to address the gap in knowledge
regarding causes and mechanisms contributing to the autoim-
mune attack on skin in chronic cutaneous lupus erythematosus
(CCLE). The raw gene expression data ﬁles (CEL ﬁles) are provided
with this article [3].
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erythematosus; NL, Normal control; B, Blood
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Organism/cell Homo sapiens
More speciﬁc
subject areaChronic cutaneous lupus erythematosus (CCLE) blood samplesHow data was
acquiredAffymetrix GeneChip HG-U95setData format Raw data: CEL ﬁles
Experimental factors CCLE patients and healthy control comparison
Experimental
featuresWe performed both unsupervised and supervised analysis and established differentially expressed
genes (DEGs) between CCLE patient and healthy control blood samples. The DEGs were then
subjected to a pathway and biological processes-based enrichment analyses in DAVID and MetacoreData source location Patients diagnosed with CCLE and more speciﬁcally, DLE were recruited into the study from the
Dermatology Outpatient Clinic of New York Presbyterian Hospital, Cornell UniversityData accessibility Data is available with this articleValue of the data The raw genome-wide transcriptional proﬁling data from CCLE and healthy patients are provided
here as CEL ﬁles and are available for further analysis. The data ﬁll a major gap in knowledge regarding the systemic changes that underlie skin speciﬁc
manifestations in cutaneous lupus. The data can be used to link differential gene expression to a broad range of biological processes
and pathways underlying the mechanism of CCLE.
1. Data, materials and methods
The raw data ﬁles (CEL ﬁles) that were used in the analysis and interpretation in [3] are available in
Supplementary information.
Sample IDs are:LE1008B
LE1009B
LE1011B
NL1004B
NL1013B
NL1014B.We used the Affymetrix Human Genome U95set GeneChip according to standard Affymetrix
protocols to analyze gene expression from blood samples of CCLE patients (n¼3) and healthy control
individuals (n¼3). We used Affymetrix expression console to check the quality of each individual CEL
ﬁle. Gene expression data was imported into Partek Genomic Suite v 6.6 as CEL ﬁles using default
parameters. Preprocessing: RMA, including log 2 transformation, quantile normalization, background
correction and median polish probe set summarization to bring mean expression values of all 6 arrays
to the same scale. We performed both unsupervised and supervised hierarchical cluster analysis and
established differentially expressed genes (DEGs). Pathway and biological processes-based analyses
were performed via enrichment analyses in DAVID and Metacore. Details of methodology used are
provided in materials and methods and supplementary materials and methods [3].Appendix A. Supplementary Information
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2014.11.006.
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